Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus

Author： Hussein Abd El-Aziz M.   Omar Nisereen M.   Sakr Hussein   Elsamanoudy Ayman Z.   Shaheen Dalia  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.3, 2011-03, pp. : 216-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin receptor substrate polymorphisms and Type 2 diabetes mellitus

By Sesti Giorgio  

Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. : 343-357

Future Medicine

Access to resources Recommend Favorite

Insulin receptor variant forms and Type 2 diabetes mellitus

By Sesti Giorgio  

Pharmacogenomics, Vol. 1, Iss. 1, 2000-02 ,pp. : 49-61

Future Medicine

Access to resources Recommend Favorite

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite

Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts

By Tamura M.   Chen Y.-J.   Howard E.F.   Tanner M.   Landon E.J.   Myers P.R.  

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 289-295

Elsevier

Access to resources Recommend Favorite

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1353-1373

Bentham Science Publishers

Access to resources Recommend Favorite